Jump to main content
Jump to site search

MedChemComm

Research and review articles in medicinal chemistry and related drug discovery science; the official journal of the European Federation for Medicinal Chemistry

Research Article

Identification of imidazo[1,2-b]pyridazine TYK2 pseudokinase ligands as potent and selective allosteric inhibitors of TYK2 signalling

*
Corresponding authors
a
Bristol-Myers Squibb Research, Princeton, USA
E-mail: ryan.moslin@bms.com
Med. Chem. Commun., 2017, Advance Article

DOI: 10.1039/C6MD00560H
Received 10 Oct 2016, Accepted 06 Dec 2016
First published online 15 Dec 2016

This article is part of themed collection: New Talent: Americas
Please wait while Download options loads
 
 
This article has not yet been cited.

Supplementary Info